JKJin Joo Kim

Jin Joo Kim

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jin Joo Kim has a total of 35 co-authors. Here are the top co-authors by number of shared publications:

  • Jin You Kim

    Department of Radiology, Biomedical Research Institute, Pusan National University Hospital, Pusan National University School of Medicine, Busan, Republic of Korea

    3 shared publications
  • Eun Young Kim

    Division of Trauma and Surgical Critical Care, Department of Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea

    1 shared publication
  • Heeseung Park

    Busan Cancer Center and Biomedical Research Institute, Department of Surgery, Pusan National University Hospital, Pusan National University School of Medicine, Busan 49241, Republic of Korea

    1 shared publication
  • Hie Bum Suh

    From the Department of Radiology, Medical Research Institute (J.Y.K., J.J.K., L.H., H.B.S., S.K.), and Busan Cancer Center (T.K.), Pusan National University Hospital, Pusan National University School of Medicine and Medical Research Institute, 1-10, Ami-Dong, Seo-gu, Busan 602-739, Republic of Korea; and Department of Radiology, Pusan National University Yangsan Hospital, Yangsan, Republic of Korea (K.S.C., K.J.N.).

    1 shared publication
  • Hong Jun Kim

    Department of Medical Oncology, College of Medicine, Kyung Hee University Hospital, 23 Kyung Hee Dae-ro, Dongdaemun-gu, Seoul 02447, Republic of Korea

    1 shared publication
  • Hyun Jin Kim

    Institute of Medical Sciences, Gyeongsang National University, Jinju, Republic of Korea

    1 shared publication

Latest Publications

  • Open Access

    Magnetic Resonance Elastography of Invasive Breast Cancer: Evaluating Prognostic Factors and Treatment Response

    by Jin Joo Kim, Jin You Kim, Yeon Joo Jeong, Suk Kim, In Sook Lee, Nam Kyung Lee, Taewoo Kang, Heeseung Park, Seokwon Lee

    Objectives: To assess the elasticity values in breast tissues using magnetic resonance elastography (MRE) and examine the association between elasticity values of invasive breast cancer with prognostic factors and the pathologic response to neoadjuvant systemic therapy (NST). Methods: A total of 57 patients (mean age, 54.1 years) with invasive breast cancers larger than 2 cm in diameter on ultrasound were prospectively enrolled. The elasticity values (mean, minimum, and maximum) of invasive breast cancers, normal fibroglandular tissues, and normal fat tissues were measured via MRE using a commercially available acoustic driver and compared. Elasticity values of breast cancers were compared according to prognostic factors and pathologic responses in patients who received NST before surgery. Receiver operating curve analysis was performed to evaluate the predictive efficacy of elasticity values in terms of pathological response. Results: Among the 57 patients, the mean elasticity value of invasive breast cancers was significantly higher than that of normal fibroglandular tissue and normal fat tissue (7.90 ± 5.80 kPa vs. 2.54 ± 0.80 kPa vs. 1.32 ± 0.33 kPa, all ps < 0.001). Invasive breast cancers with a large diameter (>4 cm) exhibited significantly higher mean elasticity values relative to tumors with a small diameter (≤4 cm) (11.65 ± 7.22 kPa vs. 5.87 ± 3.58 kPa, p = 0.002). Among 24 patients who received NST, mean, minimum, and maximum elasticity values significantly differed between the pathologic complete response (pCR) and non-pCR groups (all ps < 0.05). For the mean elasticity value, the area under the curve value for distinguishing pCR and non-pCR groups was 0.880 (95% confidence interval, 0.682, 0.976; p < 0.001). Conclusions: The elasticity values of invasive breast cancers measured via breast MRE showed a positive correlation with tumor size and showed potential in predicting the therapeutic response in patients receiving NST.


  • Open Access

    Comparison of Fused Diffusion-Weighted Imaging Using Unenhanced MRI and Abbreviated Post-Contrast-Enhanced MRI in Patients with Breast Cancer

    by Kyeyoung Lee, Yeo Jin Jeong, Ki Seok Choo, Su Bong Nam, Hyun Yul Kim, Youn Joo Jung, Seung Ju Lee, Ji Hyeon Joo, Jin You Kim, Jin Joo Kim, et al.

    Background and Objectives: To determine the percentage of breast cancers detectable by fused diffusion-weighted imaging (DWI) using unenhanced magnetic resonance imaging (MRI) and abbreviated post-contrast-enhanced MRI. Materials and Methods: Between October 2016 and October 2017, 194 consecutive women (mean age, 54.2 years; age range, 28–82 years) with newly diagnosed unilateral breast cancer, who underwent preoperative 3.0 T breast MRI with DWI, were evaluated. Both fused DWI and abbreviated MRI were independently reviewed by two radiologists for the detection of index cancer (which showed the most suspicious findings in both breasts), location, lesion conspicuity, lesion type, and lesion size. Moreover, the relationship between cancer detection and histopathological results of surgical specimens was evaluated. Results: Index cancer detection rates were comparable between fused DWI and abbreviated MRI (radiologist 1: 174/194 [89.7%] vs. 184/194 [94.8%], respectively, p = 0.057; radiologist 2: 174/194 [89.7%] vs. 183/194 [94.3%], respectively, p = 0.092). In both radiologists, abbreviated MRI showed a significantly higher lesion conspicuity than fused DWI (radiologist 1: 9.37 ± 2.24 vs. 8.78 ± 3.03, respectively, p < 0.001; radiologist 2: 9.16 ± 2.32 vs. 8.39 ± 2.93, respectively, p < 0.001). The κ value for the interobserver agreement of index cancer detection was 0.67 on fused DWI and 0.85 on abbreviated MRI. For lesion conspicuity, the intraclass correlation coefficients were 0.72 on fused DWI and 0.82 on abbreviated MRI. Among the histopathological factors, tumor invasiveness was associated with cancer detection on both fused DWI (p = 0.011) and abbreviated MRI (p = 0.004, radiologist 1), lymphovascular invasion on abbreviated MRI (p = 0.032, radiologist 1), and necrosis on fused DWI (p = 0.031, radiologist 2). Conclusions: Index cancer detection was comparable between fused DWI and abbreviated MRI, although abbreviated MRI showed a significantly better lesion conspicuity.


  • Kinetic Heterogeneity of Breast Cancer Determined Using Computer-aided Diagnosis of Preoperative MRI Scans: Relationship to Distant Metastasis-Free Survival

    by Jin You Kim, Jin Joo Kim, Lee Hwangbo, Hie Bum Suh, Suk Kim, Ki Seok Choo, Kyung Jin Nam, Taewoo Kang

    In women with invasive breast cancer, a higher degree of kinetic heterogeneity, higher peak enhancement values and histologic grades, and axillary node metastasis were associated with worse distant... Background Higher peak enhancement and washout component values measured on preoperative breast MRI scans with computer-aided diagnosis (CAD) are presumed to be associated with worse recurrence-fre...


  • Open Access

    Myxedema coma precipitated by diabetic ketoacidosis after total thyroidectomy: a case report

    by Jin Joo Kim, Eun Young Kim

    Myxedema coma is profound decompensated hypothyroidism usually precipitated by stressors, and its occurrence in association with total thyroidectomy or metabolic disorders, such as diabetic ketoacidosis, is unusual. A 43-year-old Asian man with history of total thyroidectomy who was scheduled for a second radioactive iodine therapy presented to our hospital with decreased mental status and hyperglycemia. He had a history of thyroid cancer but did not have diabetes mellitus. He was in a hypothermic state and had a Glasgow Coma Scale score of 10 out of 15 at presentation; arterial blood gas analysis revealed a state of metabolic acidosis and laboratory findings suggested hyperglycemia with glycosuria, ketoacidosis, and severe hypothyroidism. A thyroid function test showed thyroid-stimulating hormone of 34.126 uIU/mL, free thyroxine of 1.02 ng/dL, and triiodothyronine of 1.04 ng/mL. The glycated hemoglobin of this patient was checked due to hyperglycemia and the value of glycated hemoglobin was 16.5% which met the criteria for a diagnosis of diabetes. After treatment for myxedema with liothyronine 5 mcg two times per day and levothyroxine 175 mcg once daily via a nasogastric tube and diabetic ketoacidosis with intravenously administered fluid and insulin, his clinical condition rapidly improved including mental status, hyperglycemia, and acidosis. During the hospitalization, a workup for diabetes mellitus was performed and the results suggested that a diagnosis of type 2 diabetes mellitus would be appropriate. This case demonstrated that diabetic ketoacidosis not only could be a potential contributor to myxedema coma but also mask typical clinical features, making diagnosis more difficult. Considering the possibility of an increasing number of potential patients with hypothyroidism developed after thyroidectomy, constant vigilance is required for a better clinical outcome, including early recognition and management in critical care in advance for unusual diabetic ketoacidosis which could precipitate decompensated hypothyroidism.


  • Open Access

    Successful biliary cannulation by the rendezvous technique via percutaneous transhepatic gallbladder drainage: A report of two cases

    by Jae Min Lee, Ra Ri Cha, Wan Soo Kim, Jin Joo Kim, Sang Soo Lee, Hong Jun Kim, Hyun Jin Kim, Tae Hyo Kim, Woon Tae Jung, Ok Jae Lee

    Key Clinical Message: Reports of the rendezvous technique via percutaneous transhepatic gallbladder drainage are very rare because of difficulties with insertion of the guidewire from the gallbladder into the common bile duct. In particular, our report includes a case with distal common bile duct stricture. To our knowledge, such a case has never been previously reported.